Daily Newsletter

17 August 2023

Daily Newsletter

17 August 2023

Diabetes focused partnership formed between EXI and Hyperice

The new partnership will help people with diabetes and chronic conditions by offering Hyperice's Normatec dynamic air compression technology through the EXI platform.

Kiays Khalil August 17 2023

Digital therapeutics company EXI is teaming up with health and wellness brand Hyperice to offer a solution that can address pain relief for people with diabetes and chronic conditions.

Hyperice is well established as a recovery tool in the sports and athletics space offering improved warm-up and recovery conditions through various products that use air compression, contrast therapy, vibrations, and thermal and mind technology.

Recently, Hyperice partnered with the Carvana Professional Pickleball Association (PPA Tour) as its Official Recovery Technology Partner. The sport has gained popularity over the years and Hyperice gives pickleball players courtside and locker room access to a suite of recovery technology products.

Over the past few years Hyperiece has focused on increasing its offering to the public. The latest collaboration with EXI aims to provide patients with diabetes and other chronic conditions greater access to recovery devices.

Hyperice’s Normatec dynamic air compression system will be offered through the EXI platform, providing pain relief for its users living with diabetes as a particular focus and multiple long-term health conditions.

“At present, if clinicians want to provide patients with devices for home monitoring – an ECG holter monitor, for example – it’s on a short-term loan basis and inhibits positive habit changes,” EXI CEO Grace McNamara said: “By offering Normatec to our consumers, we can promote and support long-standing self-care at home utilizing technology that is backed by science.”

Speaking on the goals of the partnership, Hyperice CEO Jim Huether said: “The collaboration of technologies, specifically with our Normatec compression systems, represents a win-win for patients and clinicians, supporting improved outcomes for patients within a remotely monitored, self-care model.”

There have been multiple peer-reviewed studies on Normatec’s precision pulse technology which have shown evidence of improved conduit artery endothelial function systemically, RH blood flow in the compressed limbs and boosted oxygenated haemoglobin.

In October 2022, Hyperice partnered with Loop to provide advice and attention to patients needing immediate access to care through its on-demand, health-focused software as a service (SaaS) platform.

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close